相关实验视频

Updated: Jun 14, 2025

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System

Generation of Induced Pluripotent Stem Cells by Reprogramming Mouse Embryonic Fibroblasts with a Four Transcription Factor, Doxycycline Inducible Lentiviral Transduction System

Published on: November 13, 2009

在人类诱导的多能干干细胞中,以多西环林为媒介控制cyclin D2过度表达

Aijun Qiao¹, Yuhua Wei¹, Yanwen Liu¹

¹Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

International journal of molecular sciences

|August 29, 2024

概括

科学家们开发了一种人类诱导的多能干细胞 (hiPSCs) 的新系,用于控制环素D2 (CCND2) 表达. 这一进步使心肌细胞增殖的精确调节成为改善心肌再生疗法的必要条件.

科学领域:

干细胞生物学干细胞生物学
心血管研究研究心血管研究
基因规则基因规则

背景情况:

在人类诱导的多能干细胞 (hiPSCs) 中,循环D2 (CCND2) 的过度表达增强了心肌细胞 (CM) 的增殖,以进行心肌再生.
不受控制的CM增殖带来风险,包括瘤形成和心律失常并发症.

研究的目的:

设计一条具有严格控制CCND2表达的新型hiPSC线.
为了实现可诱导和可逆的CCND2过度表达,以实现更安全的再生医学应用.

主要方法:

hiPSCs被感染了一种可诱导多西环素的Tet-On转活剂和一个dCas9-VPR融合蛋白.
针对CCND2促进体的指导RNA被引入hiPSCs.
该系统使用多西环素 (dox) 激活,通过dCas9-VPR招募到促进体来诱导CCND2表达.

主要成果:

工程化hiPSC线 (doxCCND2-hiPSCs) 证明了依赖多西环素的CCND2表达.
在 dox 治疗后 48 小时内,CCND2 蛋白质水平显著增加.
在 dox 停用后大约 96 小时,CCND2 表达率恢复到接近基线水平.

结论:

一个具有可控制CCND2表达系统的新型hiPSC线已经成功生成.
这种系统允许精确的时间调节CCND2,为心脏修复提供了更安全的CM扩散方法.
开发的技术有望促进心脏病学领域的再生疗法.

关键词:

环林 D2 的使用.通过多西环素诱导的Tet-On交互激活器.人类诱导的多能干细胞干细胞.肌肉心脏再生再生

更多相关视频

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression

Published on: March 5, 2013

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Chromatin Modification in iPS Cells

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...